PT2720698T - Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia - Google Patents

Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

Info

Publication number
PT2720698T
PT2720698T PT12729555T PT12729555T PT2720698T PT 2720698 T PT2720698 T PT 2720698T PT 12729555 T PT12729555 T PT 12729555T PT 12729555 T PT12729555 T PT 12729555T PT 2720698 T PT2720698 T PT 2720698T
Authority
PT
Portugal
Prior art keywords
indan
schizophrenia
piperazine
trimethyl
chloro
Prior art date
Application number
PT12729555T
Other languages
Portuguese (pt)
Inventor
Holm René
Bruun Lone
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of PT2720698T publication Critical patent/PT2720698T/en

Links

PT12729555T 2011-06-20 2012-06-20 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia PT2720698T (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161498653P 2011-06-20 2011-06-20
DKPA201100465 2011-06-20

Publications (1)

Publication Number Publication Date
PT2720698T true PT2720698T (en) 2018-11-21

Family

ID=68315105

Family Applications (1)

Application Number Title Priority Date Filing Date
PT12729555T PT2720698T (en) 2011-06-20 2012-06-20 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia

Country Status (2)

Country Link
CY (1) CY1120838T1 (en)
PT (1) PT2720698T (en)

Also Published As

Publication number Publication date
CY1120838T1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
HRP20181684T1 (en) Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
IL253225A0 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
EP2760390A4 (en) Nasal insert and cannula and methods for the use thereof
PL2672966T3 (en) Pharmaceutical composition, methods for treating and uses thereof
RS61827B1 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2726066A4 (en) Dosage forms for oral administration and methods of treatment using the same
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
IL230957A0 (en) Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
EP2740729A4 (en) Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
HK1192726A1 (en) 1,2,4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases 124--5-
EP2785335B8 (en) Methods and pharmaceutical compositions for the treatment of darier disease
IL228891A (en) 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts for use in the treatment of cardiovascular disease
PT2720698T (en) Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
SI2699545T1 (en) Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
EP2789332A4 (en) Pharmaceutical composition comprising diaminodiphenylsulfone or the pharmaceutically acceptable salts thereof for preventing or treating diseases associated with decrease in bone mass
AU2011904233A0 (en) Use of meloxicam in the treatment of post operative sheep
ZA201307614B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease